January 16, 2018
Rose
Owkin, a predictive analytics company that aims to accelerates drug discovery and development, just landed $11 million in Series A funding. The round was led by Otium Venture with participation from Cathay Innovation, Plug and Play, and NJF Capital. This announcement brings the company’s total funding to $13.1 million.
from MobiHealthNews http://ift.tt/2DgXQIJ
January 16, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Florida Blue taps Welltok for member engagement platform- Aspire, Penn Medicine team up on $300M fund with built-in accelerators
- Science 37, VisualDx, and more digital health deals
- Steth IO launches digital stethoscope housed within smartphone case
- Luma Health releases automated two-messaging system for patient engagement
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment